Abstract

ABSTRACT Current research in drug discovery from medicinal plants involves the identification of safe and inexpensive lead molecule towards disease tagets. Cancer is a second major national burden leading to cause death. Reducing the nation's cancer burden is a great challenge to win the “War of cancer”. During the last decades, numerous novel compounds have been found from marine organisms with interesting pharmaceutical activities. Hence, a novel brown algae, Sargassum ilicifolium (Turner) C.Aardh belonging to Sargassaceae family has selected and the study was aimed to investigate the in vitro anti-proliferative activity of Ethanolic extract and Chloroform fraction of Sargassum ilicifolium (Turner) C.Agardh. against Colon Cancer (HT-29) and Lung Cancer (A549) cell lines. Extraction of seaweed using 70% ethanol and fractionated with various solvents. Based on phytochemical screening, chloroform fraction was selected, then it was subjected to GC-MS analysis. The 70% ethanolic exract and chloroform fraction were selected to in vitro MTT cell line assay using Colon cancer cell line (HT-29) and lung Cancer cell line (A549). The GC-MS analysis report confirmed the presence of 21 compounds and in the the invitro assay, IC 50 value showed the effective anti-proliferative activity role against colon and lung cancer cell lines. The results of the present study proved the anti proliferative effect of Sargassum ilicifolium in the area of cancer. Further, the active biomolecule in the fraction has to be isolated , charecterized the formulated product subjected to in vivo study to strengthen the anticancer activity. Keywords: Antiproliferative effect, Colon cancer, lung cancer, Sargassum ilicifolium , GC-MS analysis.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call